Expertise in
2
conditions

Hoon C. Kang

Eunpyeong St. Mary's Hospital, 
Seoul, KR 
Expertise in
2
conditions
Eunpyeong St. Mary's Hospital, 
Seoul, KR 
OverviewLocationsClinical Research

Overview

Hoon Kang practices in Seoul, Republic of Korea. Kang is highly rated in 2 conditions, according to our data. Their top areas of expertise are Autosomal Recessive Hypotrichosis, Alopecia Areata, Folliculitis, and Atopic Dermatitis.

Their clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Eunpyeong St. Mary's Hospital, Seoul, Republic of Korea
Other Locations
Gyeonggi-do, Republic of Korea
Incheon St. Mary's Hospital, Incheon 21431, Incheon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Other, Drug
Study Phase: Phase 3
Open-Label, Active Controlled, Single-Center, Phase 1 Study to Determine the Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Volunteers
Open-Label, Active Controlled, Single-Center, Phase 1 Study to Determine the Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Volunteers
Enrollment Status: Completed
Publish Date: March 26, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

70 Total Publications

Temperature-dependent electrochromic cycling performance of solution-processed WO3 films.
Temperature-dependent electrochromic cycling performance of solution-processed WO3 films.
Journal: Nanoscale
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kang's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile